Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Share-based Compensation (2016 - 2017)

Historic Share-based Compensation for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to $150000.0.

  • Eledon Pharmaceuticals' Share-based Compensation fell 7678.02% to $150000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $415000.0, marking a year-over-year decrease of 8820.02%. This contributed to the annual value of $13.1 million for FY2024, which is 10048.89% up from last year.
  • Eledon Pharmaceuticals' Share-based Compensation amounted to $150000.0 in Q3 2017, which was down 7678.02% from $130000.0 recorded in Q2 2017.
  • In the past 5 years, Eledon Pharmaceuticals' Share-based Compensation registered a high of $1.2 million during Q3 2014, and its lowest value of $29000.0 during Q4 2016.
  • For the 5-year period, Eledon Pharmaceuticals' Share-based Compensation averaged around $511562.5, with its median value being $597500.0 (2014).
  • In the last 5 years, Eledon Pharmaceuticals' Share-based Compensation soared by 60444.44% in 2015 and then tumbled by 9661.61% in 2016.
  • Over the past 5 years, Eledon Pharmaceuticals' Share-based Compensation (Quarter) stood at $101000.0 in 2013, then skyrocketed by 483.17% to $589000.0 in 2014, then skyrocketed by 45.5% to $857000.0 in 2015, then plummeted by 96.62% to $29000.0 in 2016, then surged by 417.24% to $150000.0 in 2017.
  • Its Share-based Compensation stands at $150000.0 for Q3 2017, versus $130000.0 for Q2 2017 and $106000.0 for Q1 2017.